Search

Your search keyword '"Kerst, A"' showing total 131 results
Start Over Author "Kerst, A" Publisher springer berlin heidelberg
131 results on '"Kerst, A"'

1. Exploring the interconnectedness between health-related quality of life factors among long-term adolescent and young adult cancer survivors (AYAs): a network analysis

Author

Bootsma, Tom I., van de Wal, Deborah, Vlooswijk, Carla, Roos, Daniëlle C., Drabbe, Cas, Tissier, Renaud, Bijlsma, Rhodé M., Kaal, Suzanne E.J., Kerst, Jan Martijn, Tromp, Jacqueline M., Bos, Monique E.M.M., van der Hulle, Tom, Lalisang, Roy I., Nuver, Janine, Kouwenhoven, Mathilde C.M., van der Graaf, Winette T.A., Janssen, Silvie H.M., and Husson, Olga

Published
2024
Full Text
View/download PDF

3. Upscaling e-mental health in Europe: a six-country qualitative analysis and policy recommendations from the eMEN project

Author

Gaebel, Wolfgang, Lukies, R., Kerst, A., Stricker, J., Zielasek, J., Diekmann, S., Trost, N., Gouzoulis-Mayfrank, E., Bonroy, B., Cullen, K., Desie, K., Ewalds Mulliez, A. P., Gerlinger, G., Günther, K., Hiemstra, H. J., McDaid, S., Murphy, C., Sander, J., Sebbane, D., Roelandt, J. L., Thorpe, L., Topolska, D., Van Assche, E., Van Daele, T., Van den Broeck, L., Versluis, C., and Vlijter, O.

Published
2021
Full Text
View/download PDF

5. Accuracy of diagnostic classification and clinical utility assessment of ICD-11 compared to ICD-10 in 10 mental disorders: findings from a web-based field study

Author

Gaebel, Wolfgang, Stricker, Johannes, Riesbeck, Mathias, Zielasek, Jürgen, Kerst, Ariane, Meisenzahl-Lechner, Eva, Köllner, Volker, Rose, Matthias, Hofmann, Tobias, Schäfer, Ingo, Lotzin, Annett, Briken, Peer, Klein, Verena, Brunner, Franziska, Keeley, Jared W., Brechbiel, Julia, Rebello, Tahilia J., Andrews, Howard F., Reed, Geoffrey M., Vogel, Ulrich, Hasan, Alkomiet, and Falkai, Peter

Published
2020
Full Text
View/download PDF

35. Einleitung

Author

Risch, Mandy, Kerst, Andreas, Risch-Kerst, Mandy, and Kerst, Andreas

Published
2009
Full Text
View/download PDF

41. Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor

Author

Axel Bex, Henk G. van der Poel, Simon Horenblas, Oscar R. Brouwer, J. Martijn Kerst, J.L.H. Ruud Bosch, Richard P. Meijer, and Joost M. Blok

Subjects
Adult, Male, medicine.medical_specialty, Neoplasm, Residual, Urologic Surgical Procedures, Male, Urology, medicine.medical_treatment, 030232 urology & nephrology, Testicular Germ Cell Tumor, Nonseminomatous germ cell tumor, Retroperitoneal lymph node dissection, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Testicular cancer, Robotic Surgical Procedures, Testicular Neoplasms, Interquartile range, Medicine, Humans, Neoplasm Metastasis, Survival rate, Retrospective Studies, Chemotherapy, business.industry, Robotic surgery, Neoplasms, Germ Cell and Embryonal, medicine.disease, Treatment Outcome, 030220 oncology & carcinogenesis, Inclusion and exclusion criteria, Testicular germ cell tumor, Original Article, Radiology, Teratoma, Robot-assisted retroperitoneal lymph node dissection, business
Abstract

Purpose To evaluate the outcome of robot-assisted residual mass resection (RA-RMR) in nonseminomatous germ cell tumor (NSGCT) patients with residual tumor following chemotherapy. Patients and methods Retrospective medical chart analysis of all patients with NSGCT undergoing RA-RMR at two tertiary referral centers between January 2007 and April 2019. Patients were considered for RA-RMR in case of a residual tumor between 10 and 50 mm at cross-sectional computed tomography (CT) imaging located ventrally or laterally from the aorta or vena cava, with normalized tumor markers following completion of chemotherapy, and no history of retroperitoneal surgery. Results A total of 45 patients were included in the analysis. The Royal Marsden stage before chemotherapy was IIA in 13 (28.9%), IIB in 16 (35.6%), IIC in 3 (6.7%) and IV in 13 patients (28.9%). The median residual tumor size was 1.9 cm (interquartile range [IQR] 1.4–2.8; range 1.0–5.0). Five procedures (11.1%) were converted to an open procedure due to a vascular injury (n = 2), technical difficulty (n = 2) or tumor debris leakage (n = 1). A postoperative adverse event occurred in two patients (4.4%). Histopathology showed teratoma, necrosis and viable cancer in 29 (64.4%), 14 (31.1%), and two patients (4.4%), respectively. After a median follow-up of 41 months (IQR 22–70), one patient (2.2%) relapsed in the retroperitoneum. The one- and 2-year recurrence-free survival rate was 98%. Conclusion RA-RMR is an appropriate treatment option in selected patients, potentially providing excellent cure rates with minimal morbidity. Long-term outcome data are needed to further support this strategy and determine inclusion and exclusion criteria.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results